FSA spoke with Julia Angeles, Investment Manager, Baillie Gifford, who discussed why the recent sell-off in the healthcare sector has been excessive, how AI is revolutionising the development of drugs and much more.
Tag: Baillie Gifford
The FSA Spy market buzz – 20 May 2022
Stagflation ETF; Was this all predictable? Collapsing Nasdaq; Collaborative Fund’s wisdom; Baillie Gifford’s China caution; Elon’s ESG fury; China’s borrowing; Gambling in Japan, and much more.
Headwinds fail to dampen China’s long-term appeal
Its economy is still growing, albeit more slowly, and the government has plenty of levers left to pull.
The future of mobility
A wave of revolutionary new technologies is set to transform the way we travel from A to B. Thaiha Nguyen, a Baillie Gifford investment manager, takes an in-depth look at the business of personal transport on the brink of change.
Baillie Gifford debuts QDLP strategy in China
The firm has been ramping its China business since last year.
Baillie Gifford obtains QDLP license
Just after it set up its private fund management business last year.
Baillie Gifford debuts onshore fund in China
Singapore’s APS AM is also launching more PFM funds in the mainland.
Baillie Gifford sets up team in China
The firm has relocated three of its investment staff to Shanghai from Edinburgh.
Photo gallery: FSA Fund Awards Singapore 2020
FSA presents photo highlights of the Fund Selector Asia Awards Singapore on 21 January 2020 at the Fullerton Hotel in Singapore
Shortage of A-share analysts dawns on UK firms
The inclusion of 230-odd China A-shares was a hugely symbolic moment for UK and European investors but the region’s fund industry has failed to get ahead of the curve, with most firms lacking dedicated teams of analysts or products to invest in.